Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05542160
Other study ID # G-CAZ0040161110628-1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date April 30, 2024

Study information

Verified date February 2024
Source Greenyn Biotechnology Co., Ltd.
Contact Yen-Nung Lin, MD
Phone 886-229307930
Email solin@w.tmu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract (IRK-19®) on weight management.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date April 30, 2024
Est. primary completion date February 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: 1. BMI: 25-30 kg/m2 2. Waistline circumference: ? 80 cm Exclusion Criteria: 1. Pregnant women or preparing for pregnancy. 2. Lactating women. 3. Women gave birth 6 months before the study. 4. Subject uses diuretic, corticosteroids, anti-depressant medications, or antipsychotic medications. 5. Subject has undertaken obesity-related surgeries within one year prior to the study or other surgeries within six months prior to the study. 6. Change of body weight of subject is over 5% within 3 months before the study. 7. Subject has serious diseases (e.g., cardiovascular diseases). 8. Cancer patient. 9. Subject has engaged in another study within 3 months before the study. 10. Subject uses another dietary supplement related to weight management during the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Pumpkin seed extract (IRK-19)
Placebo: Dietary fiber powder, two capsules/day (600 mg/day), continued use for 3 months Treatment: Pumpkin seed extract powder, two capsules/day (600 mg/day), continued use for 3 months

Locations

Country Name City State
Taiwan WanFang Hospital Taipei City

Sponsors (2)

Lead Sponsor Collaborator
Greenyn Biotechnology Co., Ltd. Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anthropometric measurement Body weight Week 0
Primary Anthropometric measurement Body weight Week 6
Primary Anthropometric measurement Body weight Week 12
Primary Anthropometric measurement Waist circumference Week 0
Primary Anthropometric measurement Waist circumference Week 6
Primary Anthropometric measurement Waist circumference Week 12
Primary Anthropometric measurement Hip circumference Week 0
Primary Anthropometric measurement Hip circumference Week 6
Primary Anthropometric measurement Hip circumference Week 12
Primary Body composition analysis Body fat Week 0
Primary Body composition analysis Body fat Week 6
Primary Body composition analysis Body fat Week 12
Primary Body composition analysis Visceral fat Week 0
Primary Body composition analysis Visceral fat Week 6
Primary Body composition analysis Visceral fat Week 12
Primary Body composition analysis Subcutaneous fat Week 0
Primary Body composition analysis Subcutaneous fat Week 6
Primary Body composition analysis Subcutaneous fat Week 12
Primary Biochemistry Total cholesterol Week 0
Primary Biochemistry Total cholesterol Week 6
Primary Biochemistry Total cholesterol Week 12
Primary Biochemistry Triacylglycerol Week 0
Primary Biochemistry Triacylglycerol Week 6
Primary Biochemistry Triacylglycerol Week 12
Primary Biochemistry HDL Week 0
Primary Biochemistry HDL Week 6
Primary Biochemistry HDL Week 12
Primary Biochemistry LDL Week 0
Primary Biochemistry LDL Week 6
Primary Biochemistry LDL Week 12
Primary Biochemistry Adiponectin Week 0
Primary Biochemistry Adiponectin Week 6
Primary Biochemistry Adiponectin Week 12
Primary Biochemistry Lectin Week 0
Primary Biochemistry Lectin Week 6
Primary Biochemistry Lectin Weeks 12
Primary Biochemistry Fasting blood glucose Week 0
Primary Biochemistry Fasting blood glucose Week 6
Primary Biochemistry Fasting blood glucose Week 12
Primary Biochemistry Insulin Week 0
Primary Biochemistry Insulin Week 6
Primary Biochemistry Insulin Week 12
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A